Tumour cytogenetics
[Tumorzytogenetik]
EPTIS factsheet 1353416 | Last revision 2025-04-23 | URL: https://www.eptis.bam.de/pts1353416 https://www.eptis.bam.de/pts1353416
| PT provider | ||||||||||
| PT provider | Berufsverband Deutscher Humangenetiker e.V. Berufsverband Deutscher Humangenetiker e.V. | |||||||||
| Based in | Germany | |||||||||
| Language(s) | German, English | |||||||||
| Remarks | The EQA scheme is administered via www.bvdh-ringversuche.de; please register to get full access to the information. Samples will be shipped by courier service. Aim: The EQA test aims at the evaluation of the entire process of the chromosome banding analysis in haematological neoplasias starting with the receipt of the sample and ending with the outgoing report. Procedure: A surrogate blood sample is generated by using cell lines. The sample is sent out with a fictitious request. The request includes a diagnostic question, which needs to be answered by a chromosome banding analysis. Method: The analysis has to be carried out according to the own laboratory standard operational procedures. For evaluation, the findings have to be submitted in a written diagnostic report. Criteria: Proof of target aberrations through chromosome banding analysis, correct karyotype, correct report of findings. The identification of a defined target aberration is prerequisite to attest a successful participation in the EQA test. Certificate: A certificate will be provided that states the (successful) participation in the EQA test. The certificate is valid for two years. | |||||||||
| Keywords | ||||||||||
| Product groups |
Human test material
|
|||||||||
| Testing fields |
Medical analysis
|
|||||||||
| Technical details | ||||||||||
|
||||||||||
| Aims of the PT scheme | ||||||||||
| Target group of participants | Laboratories which offer cytogenetic testing. Geographical restrictions to participation insofar as delivery of the sample within 3 days max must be possible | |||||||||
| Linked to specific legislation / standards | ||||||||||
| Additional, subsidiary aims | ||||||||||
| Number of participants | 50 | |||||||||
| Accredited or otherwise reviewed by a 3rd party |
Accredited by Deutsche Akkreditierungs-Stelle DAkkS on the basis of DIN EN ISO/IEC 17043 |
|||||||||
| Operation is commissioned / requested by | ||||||||||
| Fees and frequency | ||||||||||
| Participation fee | 400 euros net | |||||||||
| Regularly operated | Yes (Once per year) | |||||||||
| Year of first operation | 2010 | |||||||||
| Contact details of the PT provider | ||||||||||
| Provider | Contact person | |||||||||
|
Berufsverband Deutscher Humangenetiker e.V.
Linienstraße 127 10115 Berlin Germany Phone: 030 55954411 Fax: 030 55954414 Web: https://www.bvdh-ringversuche.de https://www.bvdh-ringversuche.de |
Frau Susanne Brandt
Phone: 02403 838054 Fax: Email: brandt@bvdh.de brandt@bvdh.de |
|||||||||
If you find any mistakes please contact the responsible EPTIS coordinator in Germany,
Mr Johannes van de Kreeke.
Mr Johannes van de Kreeke.